An Update on Thyroid Eye Disease

This lecture will outline and describe the current understanding of thyroid eye disease (TED) and its interrelation with Graves’ Disease. It will describe incidence, risk factors, and associated systemic signs, symptoms, and pathophysiology including Rundle’s curve. We will discuss treatment options for TED including the recent FDA approval of Teprotumumab, its clinical trials, study endpoints, and adverse reactions. Masquerading ocular findings that may be early signs of TED will be described as well as lab testing that can help with the early detection of TED will be discussed. Doctors have a knowledge need for this practice gap which means having the knowledge of how to detect, diagnose, and treat TED in an integrated, multidisciplinary method. Speaker: Dr Jacob Lang